Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-17-029615

Director sold 3,059 shares at $20.29 ($62,070)

From the SEC's structured data for this filing

Trades in this filing

Woiwode Thomas · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-12-22 Sale : show line 1 in the form −3,059 $20.29 $62,070 4,959 D
Open-market sales · 3,059 sh · avg $20.29 · $62,070
Loading xslF345X03/doc4.xml…